No Detail Found!

EXPRESSION OF BAP1 IN CLEAR CELL RENAL CELL CARCINOMA

Author(s)
Arooj Fatima Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan
Sajid Mushtaq Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan
Asif Loya Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan
Usman Hassan Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore, Pakistan
Umer Nisar Sheikh Shaukat Khanum Memorial Cancer Hospital and Research Centre, Lahore-Pakistan
Abstract
Background: BAP1 (BRCA1 associated protein 1 on chromosome 3) is a commonly mutated gene in clear cell renal cell carcinoma. Aim of the study was to evaluate the prognostic significance of BAP1 by immunohistochemistry in clear cell renal cell carcinoma. Methods: It was a descriptive case series in which data was retrospectively collected. Immunohistochemistry was used to evaluate the loss of nuclear expression of BAP1. Results: Loss of BAP1 was observed in 60% of cases of clear cell renal cell carcinoma. 27% of grade 1 tumours, 62% of grade 2 tumours, 65% of grade 3 tumours and 66% of grade 4 tumours showed loss of BAP1. Loss of BAP1 was observed in 54% cases of stage 1 tumours, 72% of stage 2 tumours and 66% of stage 3 tumours. Our study showed loss of BAP1 in 67% of cases with tumour necrosis, in 75% of cases with sarcomatoid features and in 60% of patients with distant metastasis. Conclusions: We conclude that the loss of BAP1 nuclear expression is associated with poor prognostic features. i.e., higher grade, higher stage, tumour necrosis, sarcomatoid features and distant metastasis leading to death of patients.
Publication Details
Page(s) 283-287
DOI DOI not available
Published Journal: Journal of Ayub Medical College, Volume: 34, Issue: 2, Year: 2022

Request the full text from PASTIC

Keywords
Clear Cell Renal Cell Carcinoma, BAP1, bad prognosis
0

Citations

0

Downloads

173

Views